- All Courts
- Federal Courts
- Bankruptcies
- PTAB
- ITC
Filters
Like full text docket searches?
Get docket alerts, perform legal research, get updates of major decisions and orders, use our advanced analytics, and more. Request a Demo or create your account.
Date Filed
Dollars
Find cases based on dollar amount with searches like:
$100k-$10M.
Read the details here.
Displaying 2094-2108 of
3,007 results
1602 Exhibit: Bender et al, Immunogenicity, Efficacy and Adverse Events of Adalim...
Document
IPR2017-01489, No. 1602-87 Exhibit - Bender et al, Immunogenicity, Efficacy and Adverse Events of Adalimumab in RA Patients (P.T.A.B. May. 25, 2017)
|
|
Cite Document
1502 Exhibit: File History for US Patent No 6,407,213 Vol 01
Document
IPR2017-01489, No. 1502-2 Exhibit - File History for US Patent No 6,407,213 Vol 01 (P.T.A.B. May. 25, 2017)
|
|
Cite Document
1502 Exhibit: File History for US Patent No 6,407,213 Vol 06
Document
IPR2017-01489, No. 1502-7 Exhibit - File History for US Patent No 6,407,213 Vol 06 (P.T.A.B. May. 25, 2017)
|
|
Cite Document
1581 Exhibit: Sheriff et al, Three Dimensional Structure of an Antibody Antigen Com...
Document
IPR2017-01489, No. 1581-57 Exhibit - Sheriff et al, Three Dimensional Structure of an Antibody Antigen Complex (P.T.A.B. May. 25, 2017)
|
|
Cite Document
2059 Exhibit: Foote Deposition Transcript
Document
IPR2017-01489, No. 2059-231 Exhibit - Foote Deposition Transcript (P.T.A.B. Jun. 22, 2018)
|
|
Cite Document
1699 Exhibit: Deposition Transcript of Leonard G Presta, dated May 1, 2018
Document
IPR2017-01489, No. 1699-215 Exhibit - Deposition Transcript of Leonard G Presta, dated May 1, 2018 (P.T.A.B. May. 25, 2018)
|
|
Cite Document
1696 Exhibit: Presta, Humanized Monoclonal Antibodies, 29 Ann Rep in MedChem...
Document
IPR2017-01489, No. 1696-210 Exhibit - Presta, Humanized Monoclonal Antibodies, 29 Ann Rep in MedChemistry 317 24 1994 (P.T.A.B. May. 25, 2018)
|
|
Cite Document
1711 Exhibit: Havrdova, et al, Alemtuzumab in the Treatment of MultipleSclerosis K...
Document
IPR2017-01489, No. 1711-230 Exhibit - Havrdova, et al, Alemtuzumab in the Treatment of MultipleSclerosis Key Clinical Trial Results and Considerations for Use,81 THERAPEUTIC ADVANCES I...
|
|
Cite Document
1595 Exhibit: Patent Interference No 105,744 Vol 02
Document
IPR2017-01489, No. 1595-70 Exhibit - Patent Interference No 105,744 Vol 02 (P.T.A.B. May. 25, 2017)
|
|
Cite Document
2042 Exhibit: US Patent 7375193
Document
IPR2017-01489, No. 2042-195 Exhibit - US Patent 7375193 (P.T.A.B. Mar. 8, 2018)
|
|
Cite Document
2018 Exhibit: Ex 2018 Brady Decl 1489 Pfizer IPR PUBLIC
Document
IPR2017-01489, No. 2018-180 Exhibit - Ex 2018 Brady Decl 1489 Pfizer IPR PUBLIC (P.T.A.B. Sep. 6, 2017)
|
|
Cite Document
1545 Exhibit: Slamon et al, Human Breast Cancer Correlation of Relapse and Survi...
Document
IPR2017-01489, No. 1545-38 Exhibit - Slamon et al, Human Breast Cancer Correlation of Relapse and Survival with Amplification of the HER 2neu Oncogene (P.T.A.B. May. 25, 2017)
|
|
Cite Document
1645 Exhibit: Library of Congress Copyright Record for Liu 87
Document
IPR2017-01489, No. 1645-109 Exhibit - Library of Congress Copyright Record for Liu 87 (P.T.A.B. May. 25, 2017)
|
|
Cite Document
1588 Exhibit: Kumar et al, Regulation of Phosphorylation of the c erbB 2HER2 Gen...
Document
IPR2017-01489, No. 1588-63 Exhibit - Kumar et al, Regulation of Phosphorylation of the c erbB 2HER2 Gene Product by Monoclonal Antibody and Serum Growth Factors in Human Mammary Ca...
|
|
Cite Document
1504 Exhibit: Declaration of Mr Buss in Support of Petition for Inter Partes Review of Patent No 6,407,213
Document
IPR2017-01489, No. 1504-13 Exhibit - Declaration of Mr Buss in Support of Petition for Inter Partes Review of Patent No 6,407,213 (P.T.A.B. May. 25, 2017)
|
|
Cite Document
